The global inhalable drug market is anticipated to grow at a CAGR of 3.7% over the forecast period. The key factors that drive the growth of the market include the continuous contribution by the key players operating in the market. Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Bausch Health Companies Inc., are some of the prominent players operating in the global inhalable drugs industry. Product launches, innovations, mergers, and acquisitions are some of the strategies adopted by the key players.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/inhalable-drugs-market
Some of the key activities include-
- In May 2019, GlaxoSmithKline Plc added a novel drug Trelegy to its lung medicine division.
- Further, in April 2019, Cipla Ltd. announced the launch of the novel drug Niveoli. It is an extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, targeting drug delivery to the small airways. Niveoli is mainly used in the treatment of diseases such as asthma and chronic obstructive pulmonary disorder (COPD).
- Similarly, in March 2019, Breath Therapeutics announced the beginning of global Phase 3 trials for the treatment of Bronchiolitis Obliterans Syndrome (BOS) via inhalable drugs.
Thus, such activities adopted by the key players are estimated to enhance the growth of the market over the forecast period.
Market Coverage
- Market number available for – 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segment Covered- By Application and By Route of Administration
- Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
- Competitive Landscape- Boehringer Ingelheim International GmbH, Pfizer Inc., Novartis International AG, AstraZeneca Plc, GlaxoSmithKline Plc, and Johnson & Johnson Services Inc.
Key questions addressed by the report
- What is the market growth rate?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID-19
o Most affected region/segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Inhalable Drugs Market – Segmentation
By Application
- Respiratory Diseases
- Non- Respiratory Diseases
By Route of Administration
- Nasal
- Mouth
A full report of Inhalable Drugs Market is available at: https://www.omrglobal.com/industry-reports/inhalable-drugs-market
Inhalable Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AptarGroup, Inc.
- AstraZeneca Plc
- Bausch Health Companies Inc.
- Boehringer Ingelheim International GmbH
- Cipla Ltd.
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson Services Inc.
- Medisol Lifescience Pvt. Ltd.
- Merck & Co., Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi SA
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research